BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company released its 2Q2024 results that blew past estimates as demand for its innovative wound care products accelerates. The company also outlined plans to continue and advance the rapid growth seen in 2024.
